DCB

CAS No. 6971-97-7

DCB( 3,3'-dichlorobenzaldazine )

Catalog No. M27621 CAS No. 6971-97-7

DCB is an allosteric ligand for mGluR5 and shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 Get Quote
10MG 68 Get Quote
25MG 160 Get Quote
50MG 267 Get Quote
100MG 430 Get Quote
500MG 945 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DCB
  • Note
    Research use only, not for human use.
  • Brief Description
    DCB is an allosteric ligand for mGluR5 and shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB).
  • Description
    DCB is an allosteric ligand for mGluR5 and shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB). DCB blocks the positive allosteric regulation of mGluRs with the help of 3,3′-difluorobenzaldazine (DFB).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3,3'-dichlorobenzaldazine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6971-97-7
  • Formula Weight
    277.15
  • Molecular Formula
    C14H10Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (90.20 mM)
  • SMILES
    Clc1cccc(\C=N\N=C/c2cccc(Cl)c2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Paganelli FL, et al. Lipoteichoic acid synthesis inhibition in combination with antibiotics abrogates growth of multidrug-resistant Enterococcus faecium.Int J Antimicrob Agents.?2017?Mar;49(3):355-363.
molnova catalog
related products
  • N-Benzylpalmitamide

    N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.

  • Morusin

    Morusin possesses antitumor effects of cell lines including HT-29, A549, MCF-7 and MDA-MB-231, through suppressing STAT3 and NFκB attenuation mediated apoptosis induction.

  • pp60 c-src (521-533)...

    Peptide corresponding to the pp60c-src carboxy terminal regulatory domain; phosphorylated at Tyr527. Binds to pp60c-src and pp60v-src at the SH2 domain, suppressing their tyrosine kinase activity and transforming potential.